Theravectys has received regulatory clearances from France's National Security Agency and Belgium's Federal Agency for Medicines and Health Products to commence a phase I/II clinical trial of its anti-HIV therapeutic vaccine. Using the ...
Tags: Theravectys, HIV positive patients, anti-HIV therapeutic vaccine